152 related articles for article (PubMed ID: 8194167)
1. Novel carbamate analogues of amsacrine with activity against non-cycling murine and human tumour cells.
Finlay GJ; Holdaway KM; Baguley BC
Cancer Chemother Pharmacol; 1994; 34(2):159-65. PubMed ID: 8194167
[TBL] [Abstract][Full Text] [Related]
2. Carbamate analogues of amsacrine active against non-cycling cells: relative activity against topoisomerases IIalpha and beta.
Turnbull RM; Meczes EL; Perenna Rogers M; Lock RB; Sullivan DM; Finlay GJ; Baguley BC; Austin CA
Cancer Chemother Pharmacol; 1999; 44(4):275-82. PubMed ID: 10447574
[TBL] [Abstract][Full Text] [Related]
3. Cellular responses to methyl-N-[4-9-acridinylamino)-2-methoxyphenyl] carbamate hydrochloride, an analogue of amsacrine active against non-proliferating cells.
Moreland N; Finlay GJ; Dragunow M; Holdaway KM; Baguley BC
Eur J Cancer; 1997 Sep; 33(10):1668-76. PubMed ID: 9389932
[TBL] [Abstract][Full Text] [Related]
4. Cytokinetic factors in drug resistance of Lewis lung carcinoma: comparison of cells freshly isolated from tumours with cells from exponential and plateau-phase cultures.
Finlay GJ; Wilson WR; Baguley BC
Br J Cancer; 1987 Dec; 56(6):755-62. PubMed ID: 3435703
[TBL] [Abstract][Full Text] [Related]
5. A carbamate analogue of amsacrine with activity against non-cycling cells stimulates topoisomerase II cleavage at DNA sites distinct from those of amsacrine.
Baguley BC; Leteurtre F; Riou JF; Finlay GJ; Pommier Y
Eur J Cancer; 1997 Feb; 33(2):272-9. PubMed ID: 9135499
[TBL] [Abstract][Full Text] [Related]
6. Potentiation by phenylbisbenzimidazoles of cytotoxicity of anticancer drugs directed against topoisomerase II.
Finlay GJ; Baguley BC
Eur J Cancer; 1990; 26(5):586-9. PubMed ID: 1698074
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of the action of the topoisomerase II poison amsacrine by simple aniline derivatives: evidence for drug-protein interactions.
Finlay GJ; Atwell GJ; Baguley BC
Oncol Res; 1999; 11(6):249-54. PubMed ID: 10691026
[TBL] [Abstract][Full Text] [Related]
8. Comparison of in vivo and in vitro drug sensitivities of Lewis lung carcinoma and P388 leukaemia to analogues of amsacrine.
Baguley BC; Wilson WR
Eur J Cancer Clin Oncol; 1987 Jun; 23(6):607-13. PubMed ID: 3653185
[TBL] [Abstract][Full Text] [Related]
9. Relative activity of structural analogues of amsacrine against human leukemia cell lines containing amsacrine-sensitive or -resistant forms of topoisomerase II: use of computer simulations in new drug development.
Zwelling LA; Mitchell MJ; Satitpunwaycha P; Mayes J; Altschuler E; Hinds M; Baguley BC
Cancer Res; 1992 Jan; 52(1):209-17. PubMed ID: 1309224
[TBL] [Abstract][Full Text] [Related]
10. Potential antitumor agents. 52. Carbamate analogues of amsacrine with in vivo activity against multidrug-resistant P388 leukemia.
Rewcastle GW; Baguley BC; Atwell GJ; Denny WA
J Med Chem; 1987 Sep; 30(9):1576-81. PubMed ID: 3625706
[TBL] [Abstract][Full Text] [Related]
11. Comparison of the cytotoxicity of amsacrine and its analogue CI-921 against cultured human and mouse bone marrow tumour cells.
Ching LM; Finlay GJ; Joseph WR; Baguley BC
Eur J Cancer; 1990 Jan; 26(1):49-54. PubMed ID: 2138478
[TBL] [Abstract][Full Text] [Related]
12. Potential antitumor agents. 48. 3'-Dimethylamino derivatives of amsacrine: redox chemistry and in vivo solid tumor activity.
Atwell GJ; Rewcastle GW; Baguley BC; Denny WA
J Med Chem; 1987 Apr; 30(4):652-8. PubMed ID: 3560159
[TBL] [Abstract][Full Text] [Related]
13. Chemoprotection by 9-aminoacridine derivatives against the cytotoxicity of topoisomerase II-directed drugs.
Finlay GJ; Wilson WR; Baguley BC
Eur J Cancer Clin Oncol; 1989 Dec; 25(12):1695-701. PubMed ID: 2561099
[TBL] [Abstract][Full Text] [Related]
14. In vitro and in vivo assessment of activity of new anilino-substituted analogues of amsacrine against Lewis lung carcinoma.
Rewcastle GW; Denny WA; Wilson WR; Baguley BC
Anticancer Drug Des; 1986 Nov; 1(3):215-22. PubMed ID: 3450294
[TBL] [Abstract][Full Text] [Related]
15. Derivatives of amsacrine: determinants required for high activity against Lewis lung carcinoma.
Baguley BC; Finlay GJ
J Natl Cancer Inst; 1988 Apr; 80(3):195-9. PubMed ID: 3346911
[TBL] [Abstract][Full Text] [Related]
16. Selectivity of N-[2-(dimethylamino)ethyl]acridine-4-carboxamide towards Lewis lung carcinoma and human tumour cell lines in vitro.
Finlay GJ; Baguley BC
Eur J Cancer Clin Oncol; 1989 Feb; 25(2):271-7. PubMed ID: 2702982
[TBL] [Abstract][Full Text] [Related]
17. Effects of CI-921, an analogue of amsacrine, on advanced Lewis lung tumours in mice: relevance to clinical trials.
Baguley BC; Calveley SB; Harvey VJ
Eur J Cancer Clin Oncol; 1988 Feb; 24(2):211-8. PubMed ID: 3356209
[TBL] [Abstract][Full Text] [Related]
18. (R,R)-2,2'-[1,2-ethanediylbis[imino(1-methyl-2,1-ethanediyl)]]- bis[5-nitro-1H-benz[de]isoquinoline-1,3-(2H)-dione] dimethanesulfonate (DMP 840), a novel bis-naphthalimide with potent nonselective tumoricidal activity in vitro.
Kirshenbaum MR; Chen SF; Behrens CH; Papp LM; Stafford MM; Sun JH; Behrens DL; Fredericks JR; Polkus ST; Sipple P
Cancer Res; 1994 Apr; 54(8):2199-206. PubMed ID: 8174127
[TBL] [Abstract][Full Text] [Related]
19. Mechanism of cytotoxicity of N-[2-(dimethylamino)ethyl] acridine-4-carboxamide and of its 7-chloro derivative: the roles of topoisomerases I and II.
Bridewell DJ; Finlay GJ; Baguley BC
Cancer Chemother Pharmacol; 1999; 43(4):302-8. PubMed ID: 10071981
[TBL] [Abstract][Full Text] [Related]
20. Relationship of cell cycle parameters to in vitro and in vivo chemosensitivity for a series of Lewis lung carcinoma lines.
Holdaway KM; Finlay GJ; Baguley BC
Eur J Cancer; 1992; 28A(8-9):1427-31. PubMed ID: 1515264
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
